T-VISA is robust in ovarian cancer cell lines.

Slides:



Advertisements
Similar presentations
ER  HSP90 DMSO 200  M I3C30  M DIM200  M TRYPTOPHOL Supplemental Figure 1. DIM and Tryptophol fail to induce the downregulation of ER  seen with I3C.
Advertisements

Fig. 4. miR-326, miR-330, and miR-3099 bound to the GFAP 3'-UTR and regulated GFAP expression. (A) Schematic diagram of potential binding sequence (seed.
Relative luciferase activity Relative luciferase activity
Novel Cis Element for Tissue-Specific Transcription of Rat Platelet-Derived Growth Factor β-Receptor Gene by Yasunori Takata, Yutaka Kitami, Tomikazu Fukuoka,
by Elena A. Federzoni, Peter J. M. Valk, Bruce E
A B C D Supplementary Figure 1 CMV p300
Effects of BRG1 depletion in the proliferation of lung cancer cells with amplification at the MYC family of genes and in MAX-deficient cells, after reconstitution.
by Masako Moriuchi, Hiroyuki Moriuchi, and Anthony S. Fauci
Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia by Hironori.
TCR‐mediated IL‐2 promoter activation in J.Vav1 cells.
CD74 induces TAp63 expression leading to B-cell survival
The 5′‐terminal structure of the miRNA gene cluster miR‐23a∼27a∼24‐2.
Pirh2 promotes p73 ubiquitination in vivo.
Dual-Luciferase Activation Assay with Potential Targets of ZmbZIP22.
EP4 promoter activity is induced by sulindac sulfide in T98G cells.
AZD7762 abrogated the G2 checkpoint in a novel hollow fiber assay.
The homeodomain protein Cdx2 regulates lactase gene promoter activity during enterocyte differentiation  Rixun Fang, Nilda A. Santiago, Lynne C. Olds,
Volume 20, Issue 3, Pages (September 2011)
The interferon regulatory factor ICSBP/IRF-8 in combination with PU
MD-2s fails to mediate LPS-dependent NF-κB activation and IL-8 secretion. MD-2s fails to mediate LPS-dependent NF-κB activation and IL-8 secretion. A,
Bortezomib sensitivity correlates with basal NF-κB activity in KP lung adenocarcinoma cell lines. Bortezomib sensitivity correlates with basal NF-κB activity.
Fig. 6. HERV-K activation by TDP-43 and identification of binding sites on LTR. (A and B) Stem cell–derived neurons were transfected with either pcDNA.
C-MYC induces the transcription of LIG3 and PARP1 in FLT3/ITD- and BCR-ABL1–positive cells. c-MYC induces the transcription of LIG3 and PARP1 in FLT3/ITD-
Volume 12, Issue 1, Pages (July 2007)
Molecular and Functional Analysis of the Large 5′ Promoter Region of CFTR Gene Revealed Pathogenic Mutations in CF and CFTR-Related Disorders  Sonia Giordano,
Role of p38 MAPK in Transforming Growth Factor β Stimulation of Collagen Production by Scleroderma and Healthy Dermal Fibroblasts  Madoka Sato, Daniel.
RNA Polymerase II Activity of Type 3 Pol III Promoters
Hairpin & reporter systems.
Different dsRNA expression strategies have different RNAi potential.
Allopurinol up-regulates DR5 expression in PC-3 and DU145 cells.
Multiple cis-acting elements in the IGRP promoter are required for maximal basal reporter gene expression in βTC-3 cells. βTC-3 cells were transiently.
(A) Relative expression levels of the top most down-regulated genes in LATS2L breast tumors (TCGA-BRCA dataset, see Fig 1) in the panel of breast cancer.
A and B, mRNA expression for ZNF423 (A) and BRCA1 (B) for lymphoblastoid cell lines with WT/WT (8 cell lines), WT/V (7 cell lines), and V/V (8 cell lines)
Functional promoter activity of the human COX-2 gene in HMCs
Interaction between the G6PC2 rs G and rs G alleles on G6PC2 promoter activity. βTC-3 cells were transiently cotransfected, as described.
GA blocks HIF activity and reduces HIF target expression.
Cytotoxic activity of HER2-lytic hybrid peptide.
VP16-E2 is a more potent transcriptional activator than Gal4-VP16.
Gramicidin A (GA) decreases HIF protein expression in RCC cells.
Evaluation of top candidate clones for selective killing in bispecific antibody format. Evaluation of top candidate clones for selective killing in bispecific.
H. pylori induces STAT3 nuclear translocation and transcriptional activation in a CagA-dependent manner. H. pylori induces STAT3 nuclear translocation.
Silencing hOGG1 triggers caspase-3 and caspase-7 activation in response to H2O2 in GM00637 cells. Silencing hOGG1 triggers caspase-3 and caspase-7 activation.
Effects of silvestrol and BEZ235 on translation of MYC
CCG regulates cellular localization and blocks target gene expression of MRTF. A, SK-Mel-147 cells were cotransfected with RhoC and the SRE.L reporter.
TSA-mediated changes in cell cycle inhibitor proteins.
Distribution of γ-H2AX foci on metaphase spreads from BLM-proficient and BLM-deficient cells. Distribution of γ-H2AX foci on metaphase spreads from BLM-proficient.
Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. Mitotic catastrophe symptoms caused by curcumin are followed by apoptosis. A.
Dose-dependent repression of BORIS promoter activity by DNA methylation. Dose-dependent repression of BORIS promoter activity by DNA methylation. The BORIS.
OsbZIP46 Binds to the OsPM1 Promoter and Activates OsPM1 Expression in Vivo. OsbZIP46 Binds to the OsPM1 Promoter and Activates OsPM1 Expression in Vivo.
Effect of mutations of the SRE and RCE on the Akt activation of the Fra-1 promoter. Effect of mutations of the SRE and RCE on the Akt activation of the.
Effect of G9a on the expression of GSH synthesis enzymes.
Induction of cell death in prostate cancer cells by SAHA and ZOL
Src expression in a panel of human TCC cell lines.
Targeting DCLK1 by miRNA-137.
Cocultivation of fibroblasts with epithelial cells (EP156T-luc).
PHF10 acts as a transcriptional repressor.
Colony formation of K-562 cells after 24 h (upper panel) or 48 h (lower panel) exposure to ErPC3 (20 μm) and ASO-bcr (10 μm), respectively. Colony formation.
ARID1A promotes DSB end resection.
Synergistic cytotoxicity of 17AAG and TNF treatment in human lung cancer cell lines. Synergistic cytotoxicity of 17AAG and TNF treatment in human lung.
Replication stress inhibition synergizes with DNA damaging agents in human cells. Replication stress inhibition synergizes with DNA damaging agents in.
Incorporation of the TSTA system into a single plasmid.
FOXO-responsive 3X-IRS promoter activity is reduced in LNAI cells versus LNCaP cells. FOXO-responsive 3X-IRS promoter activity is reduced in LNAI cells.
Pirh2 represses p73-dependent transactivation.
Changes in signal transduction pathway induced by gefitinib.
PKD1 associates with β-catenin and negatively regulates β-catenin/TCF transcription activity. PKD1 associates with β-catenin and negatively regulates β-catenin/TCF.
Comparison of Akt1 and Akt3 for their abilities to activate the Fra-1 promoter. Comparison of Akt1 and Akt3 for their abilities to activate the Fra-1 promoter.
ABT-888 sensitizes multiple ovarian cancer cell lines but not normal cells to FdUrd. ABT-888 sensitizes multiple ovarian cancer cell lines but not normal.
The interaction between PARsylated BRCA1 and RAP80 is required for maintaining BRCA1–RAP80–PARP1 complex integrity after DNA damage and normal HRR regulation.
CREB1 binds at the proximal region of the TGFB2 promoter and induces its transcriptional activation. CREB1 binds at the proximal region of the TGFB2 promoter.
DHA and dietary n-3 PUFAs inhibit endometrial cancer cell growth in vitro and in xenograft models. DHA and dietary n-3 PUFAs inhibit endometrial cancer.
Presentation transcript:

T-VISA is robust in ovarian cancer cell lines. T-VISA is robust in ovarian cancer cell lines. A, schematic diagram of engineered T-VISA constructs in the pGL3 backbone. B, using a panel of ovarian cancer cell lines, normal ovarian epithelial cells (NOE99, NOE115, and NOE119), and normal lung fibroblasts (WI-38), plasmid DNA and pRL-TK were transiently cotransfected with the indicated. Forty-eight hours later, dual luciferase ratio was measured and shown as relative light units (ratio) normalized to the Renilla luciferase control. The data are means of four independent experiments. Bar, SD. C, the percentage of T promoter activity normalized to that of the CMV promoter. Xiaoming Xie et al. Mol Cancer Ther 2009;8:2375-2382 ©2009 by American Association for Cancer Research